What is the difference between Cerebrolysin and Chonluten?

Cerebrolysin: Cerebrolysin is not a single peptide but a complex biologic produced by enzymatic hydrolysis of purified porcine brain tissue, containing low-molecular-weight peptides (<10 kDa) and free amino acids. ... Chonluten: A short synthetic peptide bioregulator (Glu-Asp-Gly) from the Khavinson family, marketed for bronchial/lung epithelium support. Evidence is largely Russian-language and preclinical....

Cerebrolysin vs Chonluten

Q: Can you stack Cerebrolysin and Chonluten?

Cerebrolysin (cognitive) and Chonluten (immune) are in different categories and are sometimes researched together in combined protocols. Consult a licensed provider before combining any compounds.

Head-to-head comparison of Cerebrolysin and Chonluten — mechanism, side effects, legal status, and pricing.

Cerebrolysin

Cerebrolysin is not a single peptide but a complex biologic produced by enzymatic hydrolysis of purified porcine brain tissue, containing low-molecular-weight peptides (<10 kDa) and free amino acids. Manufactured by EVER Pharma (Austria), it is registered in 50+ countries (Europe, Asia, Russia, Latin America) for ischemic stroke, traumatic brain injury, and dementia, but is NOT FDA-approved in the United States.

Profile Prices Testing

Chonluten

A short synthetic peptide bioregulator (Glu-Asp-Gly) from the Khavinson family, marketed for bronchial/lung epithelium support. Evidence is largely Russian-language and preclinical.

Profile Prices Testing

Cerebrolysin

Chonluten

Where Researchers Are Buying

Live · updated daily

COA-verified vendors · trust score ≥70 required · single-vial price — bulk/bundle deals may be lower

Cerebrolysin

3 vendors list this, but none clear the trust bar (score ≥70) yet.

Check Cerebrolysin prices →

Chonluten

Best $/mg

$3.50/mg

BioLongevity LabsC

1 trusted vendor listing

Compare all 1 vendor

Lab Verification

COA corpus from Disclosed Labs — independently tested batches only.

Cerebrolysin

COAs

—

Avg purity

Labs

Full testing data

Chonluten

COAs

99.6%

Avg purity

Labs

Full testing data

Cerebrolysin Research Summary

The CASTA trial (Heiss et al., Stroke 2012, PMID 22282884, n=1070) failed its primary endpoint in Asian ischemic stroke patients, though a post-hoc subgroup with NIHSS >12 showed favorable mortality and functional trends. The CARS trial (Muresanu et al., Stroke 2016, PMID 26564102) reported improved upper-extremity motor recovery at day 90 with 30 mL/d for 21 days alongside rehabilitation. The Guekht 2011 vascular-dementia RCT (PMID 20656516, n=242) reported ADAS-cog+ and CIBIC+ improvements vs placebo. A 2023 Cochrane review (Ziganshina et al., PMID 37818733) concluded moderate-certainty evidence that Cerebrolysin/Cerebrolysin-like peptide mixtures probably do not reduce all-cause death in acute ischemic stroke, and flagged a possible increase in non-fatal serious adverse events. Many pivotal trials are industry-sponsored, and batch-to-batch variability as a porcine-brain hydrolysate is an ongoing methodological concern.

Key references

Chonluten Research Summary

Primarily Russian institutional studies; no large independent controlled human trials.

Can you stack Cerebrolysin and Chonluten?

Cerebrolysin (Cognitive) and Chonluten (Immune) are in different categories and target different biological pathways. This is a common pattern in multi-compound research protocols. Researchers should monitor the biomarkers from both profiles and watch for interactions listed in each compound’s contraindications. Consult a licensed healthcare provider before combining any research compounds.

Other comparisons

Cerebrolysin vs Selank Chonluten vs Selank Cerebrolysin vs Semax Chonluten vs Semax Cerebrolysin vs Dihexa Chonluten vs Dihexa Cerebrolysin vs PE-22-28 Chonluten vs PE-22-28

This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.